Peptic Ulcer Clinical Trial
Official title:
Drop in Gastroscopy - Experience After 9 Months
The capacity for endoscopical procedures in the Norwegian health system is low in comparison
to demands from patients and family practitioners.
The studies aim is to evaluate the acceptance of a new concept: an open access gastroscopy
clinic where patients can attend without a preceding appointment.
The investigators wish to evaluate:
1. Patient´s satisfaction.
2. General practitioner´s satisfaction.
3. Acceptance by the staff of the clinic.
The fact that access to specialized norwegian health care is characterized by a mismatch
between system´s capacity and patient´s and refering physician´s demands, leads to delay of
diagnostic investigations such as for example gastroscopies. Patients referred to
gastroscopies have to wait 4 to 12 weeks to get an appointment. Consequence might be a delay
in diagnosing of significant diseases such as ulcers or even malignancies. In addition the
general practitioner is frequently forced to start a therapy by suspicion, and the patient
has in numerable cases to stay off work.
In September 2008, the investigators started an open-access gastroscopy outpatient clinic,
which allows the family practitioners in a defined area of the Telemark county to refer
their patients to a gastroscopy without a preceding appointment. Patients from the other
parts of the county and those, who need special service as i.e. interpreter, endocarditis
prophylaxis etc. are referred conventionally and need an appointment.
Aim of the study is to evaluate the acceptance of both forms of outpatient clinics by both
patients and general practitioners. In addition to that, the investigators will evaluate the
acceptance of the open access clinic by the staff. Of special concern is the fear, that
easier access might lead to a number of unnecessary procedures.
All patients from open access clinic and from the conventional clinic are asked to fill in a
questionaire without any kind of personal identifying data such as name, age, date of the
procedure etc., but with questions about their satisfaction with the procedure, the time
from their first contact with their family practitioner to the procedure, the information
prior and after the procedure. They will be asked if they did consume drugs against
"ulcer-disease" or not.
In addition the referring practitioners are asked to fill in a questionnaire about their
acceptance of the open access clinic, and to give the investigators some ideas about
advantages and disadvantages from their point of view.
The staff is asked to give their experience especially according to the not calculable
number of patients that attend to the clinic each day.
If the present study shows high acceptance of the open-access-offer by patients and health
workers, the plan is to extend it to other patient groups and to perform studies to
investigate the effects on the grade of diseases at the time of diagnosis and possible
consequences for treatment and health economy.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00471029 -
Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
|
Phase 4 | |
Completed |
NCT00152399 -
Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding
|
Phase 2 | |
Not yet recruiting |
NCT02961296 -
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
|
N/A | |
Completed |
NCT00212225 -
Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)
|
N/A | |
Completed |
NCT02342470 -
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
|
Phase 2 | |
Completed |
NCT02296021 -
Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
|
Phase 4 | |
Terminated |
NCT04025983 -
Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection
|
N/A | |
Recruiting |
NCT03868267 -
Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting
|
||
Completed |
NCT05237115 -
Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy
|
Phase 4 | |
Completed |
NCT01667718 -
Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment
|
Phase 4 | |
Not yet recruiting |
NCT04784910 -
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
|
Phase 3 | |
Recruiting |
NCT02436018 -
WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy
|
N/A | |
Completed |
NCT03367897 -
Bleeding Ulcer and Erosions Study "BLUE Study"
|
||
Active, not recruiting |
NCT02001727 -
HEP-FYN 12-Years Follow-up
|
N/A | |
Completed |
NCT01376414 -
H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department
|
N/A | |
Completed |
NCT01667692 -
Aizthromycin or Clarithromycin in H-pylori Eradication Regimen
|
Phase 4 | |
Completed |
NCT01080326 -
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
|
N/A | |
Completed |
NCT02536989 -
Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot
|
Phase 4 | |
Completed |
NCT00920400 -
Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract
|
N/A | |
Completed |
NCT00450658 -
Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers
|
Phase 3 |